Acute morphine lowers brain stimulation reward thresholds in rats with depressed or elevated response rates

B Hine1, M Lopez

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, San Juan 00936.

Psychopharmacology
|January 1, 1990
PubMed

Insights

Morphine sulfate (MS) significantly lowers brain reward thresholds in rats, indicating its rewarding effects are independent of behavioral changes. This study explores morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • The rewarding effects of opioids, such as morphine, are a key factor in their abuse potential.
  • Understanding the precise mechanisms underlying morphine's reinforcing properties is crucial for developing effective addiction treatments.

Purpose of the Study:

  • To investigate the relationship between acute morphine sulfate (MS) administration and brain stimulation reward in male rats.
  • To determine if the observed changes in reward threshold are independent of alterations in response rates.

Main Methods:

  • Concurrent assessment of rate-dependent and rate-independent measures of brain stimulation reward.
  • Administration of acute morphine sulfate (MS) at doses of 4 mg/kg and 1 mg/kg to male rats.
  • Comparison of reward thresholds and response rates following MS injection versus saline control.

Main Results:

  • A 4 mg/kg MS injection significantly decreased reward threshold by 28.5% and response rates by 60.6%.
  • A 1 mg/kg MS dose resulted in a 21.5% decrease in reward threshold and a 23.1% increase in response rates.
  • Decreases in reward threshold were independent of concurrent changes in response rates.

Conclusions:

  • Acute morphine administration produces a decrease in reward threshold that is independent of response rate changes.
  • Morphine's rewarding effect may be dissociated from behavioral activation or inhibition caused by different doses.

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...